Literature DB >> 3137001

Search for a scrapie-specific nucleic acid: a progress report.

B Oesch1, D F Groth, S B Prusiner, C Weissmann.   

Abstract

Scrapie agent contains a proteinaceous component as well as an 'informational' molecule (suggested by the existence of distinct strains of scrapie). These operationally defined entities may be the same molecule, an infectious protein, or distinct, in which case a nucleic acid might encode the genetic information. Purification of scrapie agent enriched a protein, PrPSc, by virtue of its relative protease resistance. There is only a single PrP gene and the primary translation product of PrP mRNA is the same in normal and scrapie-infected brain; therefore the normal PrPC and the protease-resistant isoform, PrPSc, found in scrapie, probably result from different post-translational events. To search for scrapie-specific nucleic acid, globin RNA made in vitro was added to highly purified infectious preparations at a ratio of 10(3) molecules per infectious unit, nucleic acids were isolated and denatured, and cDNA synthesized using random oligonucleotide primers. Clones containing globin-related sequences were identified by in situ hybridization. 150 plaques not hybridizing to the globin probe were isolated. Inserts larger than 50 base pairs were analysed. By hybridization to a globin probe at reduced stringency all but four clones were found to contain small globin related inserts; two of these hybridized to hamster repetitive sequences as shown by Southern blot analysis. The other clones not related to hamster nucleic acids may be derived from unknown sources of contamination or from scrapie-specific nucleic acids.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137001     DOI: 10.1002/9780470513613.ch14

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  14 in total

Review 1.  The search for scrapie agent nucleic acid.

Authors:  J M Aiken; R F Marsh
Journal:  Microbiol Rev       Date:  1990-09

Review 2.  Grafting mouse brains: from neurocarcinogenesis to neurodegeneration.

Authors:  A Aguzzi
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

3.  Potential retroviral RNAs in Creutzfeldt-Jakob disease.

Authors:  G H Murdoch; T Sklaviadis; E E Manuelidis; L Manuelidis
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

4.  Human and experimental spongiform encephalopathies: recent progress in pathogenesis.

Authors:  M C Dal Canto
Journal:  Ital J Neurol Sci       Date:  1991-04

5.  Nucleic acid binding proteins in highly purified Creutzfeldt-Jakob disease preparations.

Authors:  T Sklaviadis; A Akowitz; E E Manuelidis; L Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

6.  Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob disease.

Authors:  A Akowitz; T Sklaviadis; L Manuelidis
Journal:  Nucleic Acids Res       Date:  1994-03-25       Impact factor: 16.971

7.  Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy.

Authors:  R A Bessen; R F Marsh
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Nuclease resistant circular DNAs copurify with infectivity in scrapie and CJD.

Authors:  Laura Manuelidis
Journal:  J Neurovirol       Date:  2010-12-07       Impact factor: 2.643

9.  Search for a prion-specific nucleic acid.

Authors:  Jiri G Safar; Klaus Kellings; Ana Serban; Darlene Groth; James E Cleaver; Stanley B Prusiner; Detlev Riesner
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 10.  Transgenic and knockout mice in the study of neurodegenerative diseases.

Authors:  A Aguzzi; S Brandner; S Marino; J P Steinbach
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.